LIVALO pitavastatin 4 mg film-coated tablet blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

pitavastatin calcium, Quantity: 4.18 mg (Equivalent: pitavastatin, Qty 4 mg)

Saatavilla:

Advantage Medical Products Consulting Pty Ltd

INN (Kansainvälinen yleisnimi):

pitavastatin calcium

Lääkemuoto:

Tablet, film coated

Koostumus:

Excipient Ingredients: aluminium magnesium silicate; lactose monohydrate; hypromellose; triethyl citrate; magnesium stearate; hyprolose; titanium dioxide; colloidal anhydrous silica

Antoreitti:

Oral

Kpl paketissa:

100, 10, 30, 28

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

Livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. Prior to initiating therapy with Livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Tuoteyhteenveto:

Visual Identification: Round biconvex white film-coated tablets embossed on one side with 'KC' and '4' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2013-08-27